within Pharmacolibrary.Drugs.ATC.N;

model N03AX10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 5.5e-06,
    adminDuration  = 600,
    adminMass      = 1200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.015000000000000001,
    Tlag           = 12.0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N03AX10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Felbamate is an anticonvulsant medication primarily used in the treatment of refractory epilepsy, especially partial seizures and Lennox-Gastaut syndrome in children. Due to the risk of rare but severe adverse effects such as aplastic anemia and hepatic failure, its use is typically limited to patients unresponsive to other antiepileptic drugs.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single and multiple oral doses.</p><h4>References</h4><ol><li><p>Zaccara, G, &amp; Perucca, E (2014). Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. <i>Epileptic disorders : international epilepsy journal with videotape</i> 16(4) 409–431. DOI:<a href=\"https://doi.org/10.1684/epd.2014.0714\">10.1684/epd.2014.0714</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25515681/\">https://pubmed.ncbi.nlm.nih.gov/25515681</a></p></li><li><p> (2024). Comparison Table: Some oral antiseizure medications. <i>The Medical letter on drugs and therapeutics</i> 66(1708) e133–e140. DOI:<a href=\"https://doi.org/10.58347/tml.2024.1708b\">10.58347/tml.2024.1708b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39073881/\">https://pubmed.ncbi.nlm.nih.gov/39073881</a></p></li><li><p>Schoretsanitis, G, et al., &amp; de Leon, J (2022). Drug-drug interactions between psychotropic medications and oral contraceptives. <i>Expert opinion on drug metabolism &amp; toxicology</i> 18(6) 395–411. DOI:<a href=\"https://doi.org/10.1080/17425255.2022.2106214\">10.1080/17425255.2022.2106214</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35876180/\">https://pubmed.ncbi.nlm.nih.gov/35876180</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N03AX10;
